Adaptive Biotechnologies Announces Launch of clonoSEQ® to …
https://investors.adaptivebiotech.com/news-releases/news-release-details/adaptive-biotechnologies-announces-launch-clonoseqr-assess
WEBSEATTLE, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced the launch of its clonoSEQ ® Assay to detect minimal …
DA: 89 PA: 61 MOZ Rank: 61